Back to School: How biopharma can reboot drug development. Access exclusive analysis here
INDICATION: Pulmonary fibrosis
In vitro and mouse studies identified a hydroxamic acid-based ENPP2 inhibitor that could help treat pulmonary fibrosis. Chemical
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury